院內碼 ROAZOSI     健保價: 11
懷孕分級 B
商品英文名  Azosin S.R Tab 10mg        (停用)   
商品中文名 暢利順
成分名 alfuzosine 10mg  連結MICROMEDEX查詢
劑型 持續性藥效錠
健保碼 AB49905100
衛生署許可字號 衛署藥製字第049905號
ATC治療分類 
Anatomical 
Therapeutic 
Chemical 
Classification
(G) GENITO URINARY SYSTEM AND SEX HORMONES
  (G04) UROLOGICALS
    (G04C) DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY (同治療分類查詢)
      (G04CA) Alpha-adrenoreceptor antagonists (同類藥品查詢)
        (G04CA01) alfuzosin (同成份藥品查詢)
適應症 Benign prostatic hyperplasia
良性前列腺肥大。
常見副作用 Drowsiness, postural hypotension, syncope, asthenia, depression, headache, dry mouth, GI disturbances, edema, blurred vision, rhinitis, erectile disorders, tachycardia, palpitation, Hypersensitivity reactions; flushes; chest pain; dizziness; lack of energy.
禁忌(症) Severe hepatic impairment; history of postural hypotension and micturition syncope; intestinal occlusion; severe renal insufficiency; lactation.
常用劑量及頻次 Benign prostatic hyperplasia
Adult: 2.5 mg tid. Max dose: 10 mg daily.
Elderly: Initially, 2.5 mg bid.
Renal impairment: Initiate with 2.5 mg bid. Adjust dose according to response.
Hepatic impairment: Mild-moderate impairment: Initiate with 2.5 mg dail
最大劑量
劑量調整 May lead to hypotension. Maintain patient in supine position to restore BP. Otherwise, IV fluids and/or vasopressors may be needed. Monitor renal function
注意事項與警語 Elderly; hypertension; coronary insufficiency; angina (discontinue); renal or hepatic impairment. Monitor BP regularly. May affect ability to drIVe or operate machinery.
藥品交互作用 CYP3A4 inhibitors e.g. azole antifungals, clarithromycin, diclofenac, doxycycline, erythromycin, imatinib, isoniazid, nefazodone, nicardipine, propofol, protease inhibitors, quinidine, telithromycin, and verapamil may increase the levels of alfuzosin. Reduced serum levels when used with CYP3A4 inducers e.g. aminoglutethimide, carbamazepine, nafcillin, nevirapine, phenobarbital, phenytoin and rifamycins.
Potentially Fatal: Concurrent use with potent CYP3A4 inhibitors (e.g. itraconazole, ketoconazole or ritonavir) is contraindicated.
注射劑配製時溶液限制
健保給付規定限制 
詳細資料 

藥品外觀辨識
藥品圖檔
點圖可放大
形狀  外觀顏色 
劑型 持續性藥效錠 特徵字元 
廠商名稱 健生藥品股份有限公司 廠牌 生達